Expediting Drug Development Regulatory Pathways Globally

 

In the following Clinical Researcher article, Worldwide Clinical Trials’ Global Head of Regulatory Strategy, Aman Khera, discusses how global regulatory agencies are acting as a supportive resource for sponsors through accommodations for industry advancements such as new technologies, and expanding expedited pathways for drug development.

Questions regarding your upcoming clinical trial?